Search Videos and More
Video
Advanced care enabled by seamless collaboration
Cutting-edge technology integrated with a team-based approach, allows UCI Health to deliver precise treatment quickly and effectively.
News
David Lee, MD completes remarkable 7,000th robot-assisted prostatectomy
Lee directs the Comprehensive Prostate Cancer Program and is a nationally regarded leader in minimally invasive robot-assisted prostatectomies.
News
Getting help for thyroid eye disease
Jeremiah Tao, MD, left, and Lilangi Ediriwickrema, MD work closely with a team of specialists to treat thyroid eye disease.
News
UCI otolaryngologists among group of expert contributors to a Springer book on the aftermath of COVID-19
Sudden sensorineural hearing loss (SSNHL) has emerged as a potential complication of COVID-19 infection and vaccination.
News
UCI Health names new co-directors of the Digestive Health Institute
Dr. John G. Lee and Dr. Skandan Shanmugan will continue legacy of innovative healthcare and research.
Video
Cardiovascular simulation center opens at UCI Health
Advanced software and imaging technology enables the rehearsal of patient-specific procedures—ensuring our physicians are fully prepared before ever stepping into the operating room.
Video
Stereotactic radiosurgery (SRS) at UCI Health
These noninvasive treatments target even the smallest, hardest-to-reach tumors with sub-millimeter precision.
Video
Head and neck oncologist discusses advanced treatment paradigms presented at ASCO 2024
Hear why attending this meeting improves her ability to care for patients with metastatic disease.
Video
Surgeon presents anterior-approach hip replacement and patient-specific knee replacement
Total hip arthroplasty is arguably one of the most successful and cost-effective procedures in Orthopaedics.
Video
Next-generation testing in patients with non-small cell lung cancer
Tumor sequencing at the time of progression, whether tissue or liquid biopsy, is important to identify the mechanism of resistance.
Video
Survey of actionable driver mutations KRAS and EGFR in non–small cell lung cancer
Molecularly targeted therapies have advanced treatment for certain cancers, such as lung cancer with specific EGFR or KRAS mutations. However, oftentimes the tumor becomes eventually treatment resistant.
Video
Tumor immunologist discusses 2024 ASCO Annual Meeting late-breaking news
Nelson provides specialized care in blood disorders, hematology oncology, and medical oncology.